31 Stocks Moving In Monday’s Mid-Day Session
Gainers
Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share.
10 Biggest Price Target Changes For Wednesday
HC Wainwright & Co. lowered Novavax, Inc. (NASDAQ: NVAX) price target from $317 to $294. Novavax shares fell 1.6% to $136.00 in pre-market trading.
Goldman Sachs Downgrades Amarin Corp to Sell, Lowers Price Target to $5
Goldman Sachs analyst Paul Choi downgrades Amarin Corp (NASDAQ:AMRN) from Neutral to Sell and lowers the price target from $6 to $5.
Amarin Receives UK Marketing Authorization For VAZKEPA From Medicines, Healthcare Products Regulatory Agency 1, 2
VAZKEPA (icosapent ethyl) is the first and only authorized treatment for its cardiovascular risk reduction indication1,2,3
VAZKEPA authorization for Great Britain follows recent VAZKEPA authorization for European
Amarin Shares Rebound From Session Low, Now Up 1% For Session; Traders Circulate Link From Cigna Website Showing Changes To Prescription Drug List, Co. Added Amarin’s Vascepa To National Coverage List
https://www.cigna.com/static/www-cigna-com/docs/individuals-families/2019/2020-prescription-drug-list-changes.pdf